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Background: It is well known that the C-terminal zinc-finger-3 in transcription factor Sp1 contributes more than
the N-terminal zinc-finger-1 in determining Sp1’s DNA binding capacity. Sp1-like artificial poly-zinc-finger proteins
(ZFPs) are powerful biotechnological tools for gene-specific recognization and manipulation. It is important to
understand whether the C-terminal fingers in the Sp1-like artificial ZFPs remain crucial for their DNA binding ability.
Recently, a set of p16 promoter-specific seven-ZFPs (7ZFPs) has been constructed to reactivate the expression of
methylation-silenced p16. These 7ZFPs contain one N-terminal three-zinc-finger domain of Sp1 (3ZF), two Sp1-like
two-zinc-finger domains derived from the Sp1 finger-2 and finger-3 (2ZF) in the middle and C-terminal regions.
Results: In the present study, sets of variants for several representative 7ZFPs with the p16-binding affinity were
further constructed. This was accomplished through finger replacements and key amino acid mutations in the
N-terminal fingers, C-terminal fingers, and linker peptide, respectively. Their p16-binding activity was analysed using
gel mobility shift assays. Results showed that the motif replacement or a key amino acid mutation (S > R) at
position +2 of the α-helix in the C-terminal 2ZF domain completely abolished their p16-binding affinity. Deletion
of three amino acids in a consensus linker (TGEKP > TG) between finger-7 and the 6 × Histidine-tag in the C-terminal
also dramatically abolished their binding affinity. In contrast, the replacement of the finger-3 in the N-terminal 3ZF
domain did not affect their binding affinity, but decreased their binding stability.
Conclusions: Altogether, the present study show that the C-terminal region may play crucial roles in determining
the DNA binding affinity of Sp1-like artificial ZFPs.Background
The C2H2 zinc-finger is one of the most common
DNA-binding motifs in eukaryotes. Each C2H2 zinc-finger
domain is a simple ββα-fold peptide and consists of about
30 amino acid residues in length. Structure stability of this
fold is achieved by hydrophobic interaction by chelating of
a single zinc ion with the conserved cysteine and histidine
residues [1]. Nucleic acid recognition of zinc-finger
proteins (ZFPs) is achieved through key amino acid
residues at positions −1, +2, +3, and +6 of the α-helix in
each finger, which typically bind with three adjacent bases
(a triplet) [2,3]. A simple mode of DNA recognition by the* Correspondence: dengdajun@bjmu.edu.cn
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reproduction in any medium, provided the orC2H2 zinc-finger domain provides an ideal scaffold for
designing proteins with novel sequence specificities. To
achieve high binding specificity in the context of a large
genome, longer arrays of zinc-fingers are required [4]. The
ability of artificial ZFPs to target specific DNA sequences
has led to the development of chimerical DNA modifying
enzymes and transcription factors for specific genes
[5-9]. This in turn has opened the possibility of using
the engineered ZFP-based factors as novel human
therapeutics. Compared with two recently established
CRISPR and TALE technologies [10,11], the Sp1-like
ZFP transcription factors may still be the best choice
for gene transcription therapy because of their low
antigenicity for human beings.
It has been reported that C-terminal finger-2 and
finger-3 in transcription factor Sp1 contribute more than
N-terminal finger-1 when targeting GC-box DNA [12].Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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other C2H2 zinc-finger protein [13,14]. However, it is not
well studied whether the C-terminal domain in artificial
ZFPs is still a crucial determinant for their DNA binding
affinity. In addition, amino acid at position +2 of the α-helix
in zinc fingers might interact with the 4th DNA base on the
opposite strand of the flanking triplet DNA target. This
amino acid/base contact enables synergy between adjacent
fingers in sequence-specific DNA recognition for natural
ZFPs such as tramtrack, Zif268, and Sp1 [15-17]. It is not
clear whether the amino acid at position +2 in artificial
ZFPs plays a role in DNA recognition as well.
P16INK4A (CDKN2A/MTS1) is a cell cycle regulator
involved in inhibition of the G1 phase progression
[18]. Methylation of p16 CpG islands silences transcription
of this gene epigenetically in many cancers [19]. p16
Methylation positively correlates with the risk of malignant
transformation of human epithelial dysplasia [20,21]. In
our recent work, a group of p16-promoter specific seven
zinc-finger proteins (7ZFPs) were designed and fused
with the activator VP64 domain to construct p16-specific
artificial transcription factors (p16ATFs). These p16ATFs
could re-activate expression of methylation-silenced p16
through demethylation of CpG islands around the
transcription start site of this gene [22]. Each of these 7ZFPs
is composed of three-zinc-finger domain of the natural Sp1
(3ZF) in the N-terminal, two Sp1-like two-zinc-finger
mutants derived from the Sp1 finger-2 and −3 in the
middle and C-terminal regions. In the present study,
a set of N-terminal, C-terminal, and linker variants for the
representative 7ZFPs with p16-binding activity were further
constructed, and used for comparison of contributions of
different regions to the p16-binding activity.
Methods
Target p16 sequence, oligos, and probes
It has been reported that -622nt ~ −280nt region is the
core promoter of p16 gene and that the Sp1-binding site
within -466nt ~−451nt region (refer to the translation start
site ATG) is crucial for transcription of this gene [23,24].
Thus, a 21 bp fragment within the core promoter (Figure 1a),
including a natural Sp1-binding site (5′-ggggcgggg-3′) and
its 5′-flank 12 bp sequence (5′-gaggaaggaaac-3′), was used
as the target sequence to design p16-specific binding
proteins of artificial 7ZFPs in our recent study [22].
The p16 promoter-specific sequence of the biotin-labelled
and unlabelled double-strand DNA Probe-1 used in elec-
trophoresis mobility shift assay (EMSA) was 5′-aaggt tgtat
cgcgg aggaa ggaaa cgggg cgggg gcgga tttct-3′ that contains
the 21 bp 7ZFP binding site. A p16 5′UTR-specific
sequence containing a postulated Sp1-binding site was used
as the control probe (Probe-2: 5′-agggg ctggc tggtc accag
agggt ggggc ggacc gagtg cgctc-3′). These double-strand
probes were purified by polyacrylamide gel (PAGE).Construction of 7ZFPs
The designed p16-specific 7ZFPs were constructed as
described before [22]. Briefly, the two-zinc-finger modules
(2ZF) derived from the Sp1 zinc-finger-2 and −3 were
obtained by overlap-PCR using synthesized oligo
deoxynucleotides containing the coding sequence of
zinc-fingers, and then ligated together with the N-terminal
3ZF modules by particular restriction enzyme (Figure 1b).
Furthermore, various N-terminal and C-terminal finger
or linker variants were respectively constructed for the rep-
resentative 7ZFPs that could bind with the p16 promoter
specifically using various oligos DNA (Figure 1c and Table 1).
All of these 7ZFPs and their variants were inserted
into T-cloning vector and confirmed by sequencing.
Preparation of soluble 7ZFPs
7ZFP-coding sequences in T-cloning vectors were digested
by NcoI and XhoI restriction enzymes, and then inserted
into six different kinds of expression vectors including
pET-28a, pET-30a, pET-32a, pMal-p2X, pGEX-4 T-1, and
pQE-Trisystem. These constructs were transformed into
the corresponding expression bacteria and cultured in
LB medium overnight. After the density of the culture
was adjusted to 0.5 OD600nm with the fresh medium,
7ZFPs expression was induced by addition of IPTG
(Genview, USA) to the medium (final concentration,
0.1 mM) under different temperatures for different
culture times. The sonicated bacteria proteins were
separated by SDS-PAGE and visualized by Coomassie
Blue staining. The amounts of soluble 7ZFPs from diffe-
rent expression vectors were compared with each other to
select an optimal expression vector for preparation of the
soluble ZFPs as described below.
After the IPTG-induction of expression of 7ZFPs in
the above tested vectors, the bacteria were pelleted by
centrifugation, and then frozen at −80°C if necessary.
The pellets were re-suspended in 2 ml cold PBS/0.1%
NP-40 buffer per 10 ml bacteria culture and lysed by
ultrasonication followed by centrifugation (10000 rpm
for 10 min). The soluble 7ZFPs were purified from
the sonicated supernatants through incubation with
Ni-NTA-Sepharose beads (GE Healthcare, German)
for 1 hr, and eluted from the beads with 500 mmol/L of
imidazole, according to the protocol of the instruction
manual. The purified proteins were subjected to electro-
phoresis and Western blot to confirm their size and purity.
Western blot
The proteins were electrophoresed through 12%
SDS-PAGE and then transferred onto PVDF membranes.
After blocking with 5% fat-free milk overnight at 4°C, the
primary monoclonal antibody against 6 × Histidine-tag
(Beijing PuLiLai Company, China) were applied at
1:2000 dilutions for 1 hr at room temperature. After
ab
c
Figure 1 Illustration of different 7ZFP variants. (a) The 21 bp p16 promoter target sequence, including the Sp1-binding site (9 bp) and its
5′-flanking sequence (12 bp, underlined); The zinc-finger directly binding deoxynucleotides are marked with bold characters; (b) Motifs in the
artificial 7ZFP construction and their binding deoxynucleotides; fingers in pink or blue frames derived from Sp1 finger-3 and finger-2, respectively;
(c) Locations of different alterations in the 7ZFP variants (deep red bars and arrow).
\
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horseradish peroxidase-conjugated secondary antibody for
1 hr. The signals were visualized using the Enhanced
Chemoluminescence kit (PIERCE, USA).
Electrophoresis mobility shift assay (EMSA)
Light Shift Chemiluminescent EMSA Kit (PIERCE, USA)
was used. The EMSA assay was carried out according to
the protocol of the Kit instruction as described previously
[22]. Briefly, 5 nmoles of the biotin-labelled p16-promoter
specific probes was incubated with 2 μl of the tested protein
for 30 min on ice in 1 × binding buffer (25 mM HEPES,
100 mM KCl, 1 mM EDTA, 10 mMMgCl2, 0.1% NP40, 1%
glycerol, 1 mM DTT). The reaction mixture were run on a
7% polyacrylamide/0.5 × TBE gel containing 2.5% glycerol
at 100 V for 80 min and then transferred onto
Hybond N + nylon membrane (Amersham, USA). In the
competition assay, 25-, 200-, and 400-fold excesses of the
corresponding unlabeled probes were pre-incubated with
the tested proteins for 30 min prior to the addition of
the labelled probes.
Results
Design and construction of 7ZFP variants
To evaluate the contribution of each domain in active
artificial ZFPs to DNA binding activity, sets of 7ZFPs
variants containing key amino acid mutations, finger
replacements, and linker deletion in the C-terminal
and N-terminal regions were designed and constructed
respectively for the representative 7ZFPs which strongly
bind to the p16 target DNA (Figure 1), according to our
recently report [22]. These variants includes, [I] two kinds
of finger-replacement mutants in the N-terminal 3ZF and
C-terminal 2ZF domains [Table 1, lines 2 ~ 7: Variant-A/B
(f3) and Variant-B/C( f 6f 7)]; [II] two sets of mutants
containing a S > R amino acid mutation at position +2
of finger-6 in the C-terminal 2ZF domain (Table 1,
lines 8 ~ 21, Variant-D ~ J); and [III] a linker mutantwith a deletion of three amino acids (TGEKP> TG)
between finger-7 and 6×Histidine-tag in the C-terminal
region (Table 1, lines 22 ~ 23,Variant-K).
Optimisation of conditions for soluble 7ZFP preparation
To obtain soluble 7ZFPs, two distinct representative 7ZFPs
[Active-H and Variant-F(f6) with the maximum number of
amino acid differences] were inserted into six different
kinds of expression vectors, including pET-28a, pET-30a,
pET-32a, pMal-p2X, pGEX-4T-1, and pQE-Trisystem.
Following transforming these vectors, the expression level
and percentage of the soluble 7ZFPs in the corresponding
bacteria were compared under various culture temperatures
(10°C, 17°C, and 25°C) and IPTG induction times (12 hr
and 24 hr). Results showed that soluble Active-H was most
efficiently expressed in the pET-28a vector-transfected
Rosetta (DE3) bacteria, after treatment of 0.1 mM of IPTG
at 17°C for 24 hr (Figure 2). Most 7ZFPs expressed in
the pET-28a vector were dissolved in the sonicated
supernatants (about 25 kD). Similar results were obtained
for Variant-F(f6) (data not shown). Therefore, the pET-28a
vector was used to express the soluble 7ZFPs for further
experiments. After purification using Ni-NTA-Sepharose
beads, the soluble 7ZFPs were detected as a marked spe-
cific band and confirmed by Western blot (Figure 3). Such
a band was not observed in the uninduced or pET-28a
transformed-control bacteria.
Comparison of DNA binding affinity and specificity of
7ZFPs with their variants
As previously reported [22], results in the EMSA assays
using the purified 7ZFPs showed that the representative
7ZFPs including Active-A to -K had high affinity binding
to the p16 promoter-specific Probe-1 (Figures 4, 5, and
Table 1). First, we investigated whether substitution of
single amino acid mutation (S > R) at position +2 of
finger-6′s α-helix in the C-terminal 2ZF could affect
the Probe-1 binding affinity. As shown in Figure 4a,
Table 1 List of the target triplets, amino acid residues at the position −1 ~ +6 of the α-helix of each single-zinc-finger domain of active 7ZFPs and their binding
activity
Active 7ZFPs and their
variants marked with
the line number
p16 DNA
binding activitya
N-terminal Sp1 three-zinc-finger
domain (3ZF) and its mutants
Middle Sp1-like two-zinc-finger
modules (2ZF)
C-terminal Sp1-like
two-zinc-finger
modules (2ZF)
C-terminal linker
between finger-7 &
6 × His-tag
finger-1 finger-2 finger-3 finger-4 finger-5 finger-6 finger-7
5′-ggg-3′ 5′-gcg-3′ 5′-ggg-3′ 5′-aac-3′ 5′-gga-3′ 5′-gaa-3′ 5′-gag-3′
● Finger motif replacement
1_Active-A (consensus)b (++) KTSHLRA RSDELQR RSDHLSK ESDNLSQ QSGHLQR QSSNLQR RSDNLAR TGEKP
2_Variant-A (f3) (++) −−−−−−− c −−−−−−− Q−G−−QR −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−
3_Active-B (++) −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−T− −−−−−
4_Variant-B (f3) (++) −−−−−−− −−−−−−− Q−G−−QR −−−−−−− −−−−−−− −−−−−−− −−−−−T− −−−−−
5_Variant-B (f6f7) (−) −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−−− D−G−−R− Q−GH−Q− −−−−−
6_Active-C (++) −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−T−−−− −−−−−−− −−−−−T− −−−−−
7_Variant-C (f6f7) (−) −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−T−−−− D−G−−R− Q−GH−Q− −−−−−
● Single key amino acid mutation
8_Active-D (+) −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−V− −−−A−Q− −−−−−
9_Variant-D (f6) (−) −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−R−−V− −−−A−Q− −−−−−
10_Active-F (++) −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−T−−−− −−−−−V− −−−−−T− −−−−−
11_Variant-F (f6)d (−) −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−T−−−− −−R−−V − −−−−−T− −−−−−
12_Active-G (++) −−−−−−− −−−−−−− −−−−−−− D−G−−RV −−−−−−− −−−−−V− −−−−−T− −−−−−
13_Variant-G (f6) (−) −−−−−−− −−−−−−− −−−−−−− D−G−−RV −−−−−−− −−R−−V − −−−−−T− −−−−−
14_Active-Hc (+) −−−−−−− −−−−−−− −−−−−−− D−G−−RV −−−−−−− −−−−−V− −−−A−Q− −−−−−
15_Variant-H (f6) (−) −−−−−−− −−−−−−− −−−−−−− D−G−−RV −−−−−−− −−R−−V− −−−A−Q− −−−−−
16_Active-I (++) −−−−−−− −−−−−−− −−−−−−− D−G−−RR −−−−−−− −−−−−V− −−−−−T− −−−−−
17_Variant-I (f6) (−) −−−−−−− −−−−−−− −−−−−−− D−G−−RR −−−−−−− −−R−−V − −−−−−T− −−−−−
18_Active-J (+) −−−−−−− −−−−−−− −−−−−−− D−G−−RR −−T−−−− −−−−−V− −−−A−Q− −−−−−
19_Variant-J (f6) (−) −−−−−−− −−−−−−− −−−−−−− D−G−−RR −−T−−−− −−R−−V− −−−A−Q− −−−−−
20_Active-K (++) −−−−−−− −−−−−−− −−−−−−− D−G−−RR −−T−−−− −−−−−V− −−−−−T− −−−−−
21_Variant-K (f6) (−) −−−−−−− −−−−−−− −−−−−−− D−G−−RR −−T−−−− −−R−−V − −−−−−T− −−−−−
● C-terminal linker deletion
22_Active-K (++) −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−V− −−−−−T− −−−−−
23_Variant-K (linker) (−) −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−−− −−−−−V− −−−−−T− TG
aanalyzed in EMSA assays.
bthe exact sequence of amino acids of 7ZFP Active-A: N-MASRDPGKKKQHICHIQGCGKVYGKTSHLRAHLRWHTGERPFMCTWSYCGKRFTRSDELQRHKRTHTGEKKFACPECPKRFMRSDHLSKHIKTHQTGEKPFMCTWSYCGKRFTESDNLSQ
HKRTHTGEKKFACPECPKRFMQSGHLQRHIKTHTGEKPFMCTWSYCGKRFTQSSNLQRHKRTHTGEKKFACPECPKRFMRSDNLARHIKTHTGEKPFLEHHHHHH-C.
cthe symbol “−” means the amino acid residue is the same as that in the consensus sequence of Active-A at the same position in the same column. dused in optimization assays for soluble 7ZFP preparation.
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Figure 2 Comparison of the expression states of the soluble 7ZFP Active-H in various kinds of vectors under different culture
temperatures and IPTG-induction times (T: whole bacteria; S: the supernatant; P: precipitate).
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http://www.biomedcentral.com/1472-6750/13/106compared with Active-G and Active-I, this substitution
completely abolished their binding ability with Probe-1
(compare lane 2 and 3, lane 4 and 5, also see Table 1, line
12 to 13 and line 16 to 17). The EMSA experiments with
7ZFPs Active-D, F, H, J, K and their variants also showed
the same results (EMSA image not shown, and Table 1,
line 8 to 11, line 14 to 15, and line 18 to 21). Second, for
7ZFP Active-K, a deletion (TGEKP > TG) of 3 amino acid
residues in the linker between C-terminal finger-7 and the25kD
6 His Ab
1 2 3 4 5a
b
Figure 3 Total protein and purified 7ZFP Active-H in different
preparations from Rosetta DE3 bacteria transformed with the
pET-28 7ZFP or empty control vectors. (a) Total crude proteins
expressing 7ZFP (line-pointed band), Coomassie Blue staining.
(b) The expression of 7ZFP Active-D was displayed in Western blot
assay using antibody against 6 × Histidine-tag (Lane-1, total protein
for pET-28a control vector; Lane-2, total protein for pET-28a-7ZFP
vector; Lane-3, the sonicated supernatant for pET-28a-7ZFP vector;
Lane-4, the sonicated precipitate for pET-28a-7ZFP vector; Lane-5, 7ZFP
purified from the sonicated supernatant using Ni-NTA-Sepharose beads).6 × Histidine-tag also fully destroyed p16 binding
(Figure 4b, compare lane 6 and 7, Table 1, line 22 and 23).
Next, full depletion of p16 binding activity was also observed
for the representative 7ZFPs Active-B and Active-C after their
finger-6 and −7 were replaced with finger-4 and −5 (Figure 4b,
compare lane 2 and 3, lane 4 and 5; Table 1, compare line 3
and 5, line 6 and 7). In contrast, the replacement of finger-3
at the N-terminal 3ZF domain with finger-5 in 7ZFPs
Active-A and Active-B did not affect their p16 binding
affinity (Figure 5a, compare lane 2 and 6; Figure 5b, compare
lane 2 and 6; Table 1, compare line 1 and 2, line 3 and 4).
These results suggest that the C-terminal fingers and flanking
sequence may play a crucial role in determining the 7ZFPs’
DNA binding affinity.
Competition EMSA assays using unlabeled Probe-1
and Probe-2 were further carried out to investigate
whether the N-terminal domain in 7ZFPs contributes
to the p16-binding specificity. Results showed that
pre-incubation with the unlabeled p16 promoter-specific
Probe-1 (25×) completely blocked the binding of both
7ZFPs Variant-A( f 3) and Variant-B( f 3) to Probe-1
(Figure 5a, compare lane 6 and 7; Figure 5b, compare
lane 6 and 7), but only partially decreased the binding
of their active counterparts Active-A and Active-B to
Probe-1 (Figure 5a, compare lane 2 and 3; Figure 5b,
compare lane 2 and 3). Moreover, the pre-incubation with
the unlabeled Probe-2 (a p16 5′UTR sequence containing a
Sp1 binding site) did not decrease the DNA binding activity
of 7ZFPs Active-A, Active-B (Figure 5a, lane 5 and Figure 5b,
lane 5), nor their N-terminal 3ZF-variants Variant-A( f3)
and Variant-B( f3) (Figure 5a, lane 9 and Figure 5b, lane 9).
These results imply that 7ZFP N-terminal variants
can specifically bind to the p16 promoter target sequence
with a decreased binding stability.
Figure 5 Regular and competition EMSA assays for the binding
of the purified 7ZFPs to the p16 promoter specific Probe-1.
(a and b) The binding activity of 7ZFPs to the Probe-1 DNA was
partially abolished after finger 3 (RSDHLSK) in the 7ZFPs Active-A and
Active-B was replaced with finger-5 (QSGHLQR). Probe-2 is the fragment
of p16 5′UTR region containing a postulated Sp1 binding site.
Figure 4 Results of EMSA assay for the binding of the purified
7ZFPs to the p16-specific Probe-1. (a) The binding activity of
7ZFPs to the Probe-1 DNA was abolished after the S to R mutation
in finger 6 in the 7ZFPs Active-G and Active-I; Variant-(f6), variants with
a S to R mutation of the key amino acid at the position +2 of the
α-helix in finger-6 in 7ZFPs; (b) The binding activity of 7ZFPs to the
Probe-1 DNA was abolished when their C-terminal 2ZF domain in
was replaced with the middle 2ZF domain in the 7ZFP Active-B and
Active-C, or the linker between finger-7 and the 6Histidine-tag in the
C-terminal region was shorten from TGEKP to TG in the
7ZFP Active-K.
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The engineered DNA-binding proteins can be utilized to
carry out a variety of cellular activities by combining
them with different functional domains. Researchers have
successfully designed novel nucleases and transcription
factors using the C2H2-type zinc finger domain as a
scaffold [5-9]. However, the general principles of which
zinc finger or which key amino acid in the engineered
ZFPs play more important roles in the target binding are
not well studied, especially for those containing mul-
tiple zinc fingers. In the present study, we found that
the C-terminal region (finger and linker) in the artificial
ZFPs played a more important role than the N-terminal
region in determining their DNA binding affinity, and that
the N-terminal fingers could stabilize their binding to
the target DNA. Similar phenomena have previously
been reported for several natural ZFPs [12-14]. How-
ever, to the best of our knowledge, this is the first
report to show the functional difference between the
N-terminal and C-terminal regions within the engineered
ZFPs. These findings may be useful for ZFP engineering.
Sp1 is an important transcription factor that binds to se-
veral thousands of GC-boxes with the consensus sequence
5′-GGGGCGGGG-3′ in the genome. It is an ideal scaffold
for adding more zinc-fingers to its three-zinc-finger domain
and obtaining better gene-specificity for the engineeredtranscription factors because of its accessibility to
GC-boxes within chromatin and low antigenicity. It
has been reported that contribution of the C-terminal
finger-3 in natural C2H2 ZFPs to their DNA-binding
affinity is higher than the N-terminal fingers-1, and
further that finger-1 can stabilize their DNA-binding
[12-14]. In our study, C-terminal finger 3-in the natural Sp1
was used to construct 7ZFPs at its N-terminal. Interestingly,
after the 7ZFP finger-3 [RSDHLSK] in 7ZFPs Active-A and
Active-B was replaced with the finger-5 [QSGHLQR], these
7ZFP variants showed the same DNA binding affinity;
however, their DNA binding stability was decreased.
These results indicate that the functions of finger-3
are changed after its location shifts from C-terminal
in Sp1 to N-terminal in 7ZFPs. As in the natural Sp1, the
N-terminal fingers in the Sp1-like artificial ZFPs may play
additional roles in stabilization of their DNA binding and
few roles in determining their DNA binding affinity.
Studies on Zif268 and artificial ZFPs have suggested
that the amino acid at position +2 of the α-helix of each
finger might be able to interact with the 4th DNA base
on the opposite strand of the flanking triplet DNA target,
leading to synergy between adjacent fingers and enhancing
specificity of the amino acids at other positions [15-17,25].
Amino acids with shorter and smaller side chains in
artificial ZFPs are generally used for recognition of the 2nd
and 4th DNA bases in artificial ZPF design [26]. Aspartic
acid [D] and serine [S] exist frequently at position +2 of
each α-helix in zinc-fingers. In order to investigate whether
the C-terminal fingers in the Sp1-like artificial ZFPs remain
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in the natural Sp1, C-terminal 2ZF variants containing
the key amino acid mutation [from serine (with a
polar but un-charged short side chain) to arginine
(with a charged long side chain), S > R] at position +2
of the α-helix in the finger-6, or whole 2ZF domain
replacement (from the C-terminal 2ZF to the middle 2ZF)
were constructed and used for evaluation of DNA binding
affinity changes in EMSA assay. As expected, both the
S > R mutation and C-terminal 2ZF replacement com-
pletely impaired the affinity of their corresponding 7ZFPs.
These results show that the C-terminal domain in the
Sp1-like artificial ZFPs remains important in determining
the DNA binding affinity, as observed in the natural Sp1.
It has been reported that Kaiso uses all three fingers as
well as the flanking sequences for high-affinity binding
to target DNA and that extended linker may be helpful
for the DNA binding of ZFPs [14,27]. In the present
study, it was found that deletion of three amino acid
residues in the linker between the C-terminal finger-7
and 6 × Histidine-tag also completely abolished the
binding affinity of 7ZFPs to p16 promoter-specific
DNA. This suggests that the proper flexibility of the
adjacent amino acid sequence flanking the C-terminal
fingers is also a determinant for the high DNA binding
affinity of the Sp1-like ZFPs.
Conclusions
The present study show for the first time that the
C-terminal domain in the Sp1-like artificial ZFPs
may play a crucial role in determining ZFPs’ binding
affinity to the target DNA and that the N-terminal
domain may help stabilizing this binding affinity.
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